Clinical Trial Update: Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating pembrolizumab combined with ultrasound-induced microbubble cavitation for head and neck cancer is currently recruiting. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Small Cell Carcinoma of the Head and Neck

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Head and Neck Cancer, Head and Neck Small Cell Carcinoma | Phase 1 | Status: RECRUITING